JP2011518842A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518842A5
JP2011518842A5 JP2011506485A JP2011506485A JP2011518842A5 JP 2011518842 A5 JP2011518842 A5 JP 2011518842A5 JP 2011506485 A JP2011506485 A JP 2011506485A JP 2011506485 A JP2011506485 A JP 2011506485A JP 2011518842 A5 JP2011518842 A5 JP 2011518842A5
Authority
JP
Japan
Prior art keywords
formulation
galactomannan
diol
cis
borate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011506485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518842A (ja
JP5659149B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/041699 external-priority patent/WO2009132294A1/en
Publication of JP2011518842A publication Critical patent/JP2011518842A/ja
Publication of JP2011518842A5 publication Critical patent/JP2011518842A5/ja
Application granted granted Critical
Publication of JP5659149B2 publication Critical patent/JP5659149B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011506485A 2008-04-26 2009-04-24 ポリマー性人工涙液系 Active JP5659149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4817508P 2008-04-26 2008-04-26
US61/048,175 2008-04-26
PCT/US2009/041699 WO2009132294A1 (en) 2008-04-26 2009-04-24 Polymeric artificial tear system

Publications (3)

Publication Number Publication Date
JP2011518842A JP2011518842A (ja) 2011-06-30
JP2011518842A5 true JP2011518842A5 (https=) 2013-03-14
JP5659149B2 JP5659149B2 (ja) 2015-01-28

Family

ID=40886688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506485A Active JP5659149B2 (ja) 2008-04-26 2009-04-24 ポリマー性人工涙液系

Country Status (17)

Country Link
US (3) US20090270345A1 (https=)
EP (1) EP2278954B1 (https=)
JP (1) JP5659149B2 (https=)
KR (1) KR101592872B1 (https=)
CN (1) CN102046150B (https=)
AR (2) AR071834A1 (https=)
AU (1) AU2009240488B2 (https=)
BR (1) BRPI0910717A2 (https=)
CA (1) CA2722508C (https=)
CL (1) CL2009000985A1 (https=)
ES (1) ES2818619T3 (https=)
MX (1) MX2010011736A (https=)
NZ (1) NZ589323A (https=)
TW (1) TWI526213B (https=)
UY (1) UY31785A1 (https=)
WO (1) WO2009132294A1 (https=)
ZA (1) ZA201007644B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
BRPI0910717A2 (pt) * 2008-04-26 2015-09-29 Alcon Res Ltd sistema polimérico de lágrima artificial
TWI547522B (zh) 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
PH12012501111A1 (en) * 2009-12-03 2016-09-09 Novartis Ag Carboxyvinyl polymer-containing nanoparticles suspensions
CA2798069C (en) * 2010-05-05 2016-07-05 Howard Allen Ketelson Stabilized ophthalmic galactomannan formulations
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
US20130344619A1 (en) 2012-06-21 2013-12-26 Lightship Medical Limited Glucose sensor
TWI884130B (zh) * 2018-02-21 2025-05-21 瑞士商愛爾康公司 基於脂質的眼用乳劑
US11730699B2 (en) 2018-02-21 2023-08-22 Alcon Inc. Lipid-based ophthalmic emulsion
JP6705495B1 (ja) * 2018-12-26 2020-06-03 株式会社Jvcケンウッド 車両用記録制御装置、車両用記録装置、車両用記録制御方法およびプログラム
WO2020177714A1 (zh) * 2019-03-04 2020-09-10 中山大学中山眼科中心 一种羊毛甾醇前药化合物的组合物及其制备方法和应用
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
JP7419499B2 (ja) 2019-09-18 2024-01-22 アルコン インク. 湿式充填のソフトヒドロゲル眼用インサート
CN114191378A (zh) * 2021-11-23 2022-03-18 温州医科大学附属眼视光医院 一种地夸磷索缓释凝胶及其制备方法与应用
WO2025186703A1 (en) 2024-03-04 2025-09-12 Alcon Inc. Carbamoylphenylboronic acid-containing acrylic monomers and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
GB1593954A (en) * 1977-01-31 1981-07-22 American Home Prod Xanthan gum or locust bean gum topical therapeutic compositions
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
AU8570498A (en) * 1997-07-29 1999-02-22 Alcon Laboratories, Inc. Switchable viscoelastic systems containing galactomannan polymers and borate
DE69839355T2 (de) * 1997-07-29 2009-06-04 Alcon Laboratories, Inc., Fort Worth Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
EP1696878A1 (en) * 2003-12-11 2006-09-06 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
DE102006031500A1 (de) 2006-07-06 2008-04-17 Henkel Kgaa O/W-Emulsion
US20100021561A1 (en) * 2006-09-21 2010-01-28 Chowhan Masood A Self-preserved aqueous pharmaceutical compositions
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
BRPI0910717A2 (pt) * 2008-04-26 2015-09-29 Alcon Res Ltd sistema polimérico de lágrima artificial
CA2798069C (en) * 2010-05-05 2016-07-05 Howard Allen Ketelson Stabilized ophthalmic galactomannan formulations

Similar Documents

Publication Publication Date Title
JP2011518842A5 (https=)
PE20110573A1 (es) Sistema de administracion de drogas que contiene progestina
JP2012525474A5 (https=)
WO2014186742A3 (en) Anhydrous hydrogel composition
MY161432A (en) Absorbent article
CR9704A (es) Composicion farmaceutica de liberacion modificada, proceso de preparacion y metodo para emplear la misma.
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
AR044131A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
DOP2012000245A (es) Composiciones sólidas
WO2015099985A3 (en) Cationic materials and formulations for drug delivery
BR112013016662A2 (pt) composições biodegradáveis para administração de fármaco
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
MX341873B (es) Formulaciones solidas de retardo basadas en dispersiones solidas.
JP2013525493A5 (https=)
WO2009074351A3 (en) Solid forms of tenofovir disoproxil
MX2010005013A (es) Composiciones intranasales.
WO2014116876A8 (en) Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
PH12015501982A1 (en) Pharmaceutical compositions comprising everolimus
CO7071123A2 (es) Formulaciones basadas en dispersiones solidas
WO2015092811A3 (en) Oral films
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
JP2015514739A5 (https=)
JP2011513393A5 (https=)
MX340436B (es) Formulacion farmaceutica estable con descoloramiento limitado.
MX2021008248A (es) Composicion farmaceutica.